Arch Fam Med
Institution: CLOCKSS  | My Account | E-mail Alerts | Access Rights | Sign In
  Vol. 3 No. 6, June 1994 TABLE OF CONTENTS
 • Online Features
  Original Contributions
 This Article
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Effect of Oral Magnesium Supplementation on Selected Cardiovascular Risk Factors in Non—Insulin-Dependent Diabetics

John R. Purvis, MD; Doyle M. Cummings, PharmD; Pamela Landsman, MPH; Rob Carroll, PhD; Hisham Barakat, PhD; John Bray, PhD; Christy Whitley, PharmD; Ronnie D. Horner, PhD

Arch Fam Med. 1994;3(6):503-508.

Article references have been provided for searching and linking. Additional reference information may be available in the article PDF.

1. Kobayashi J. On geographical relationship between the chemical nature of river water and death-rate from apoplexy (preliminary report). Berichte Ohara Inst Landwirtsch Biol. 1957;11:12-21.
2. Purvis JR, Movahed A. Magnesium and potassium in diabetes and carbohydrate metabolism. Clin Cardiol. 1992;15:556-568. PUBMED
3. Durlach J, Collery P. Magnesium and potassium in diabetes and carbohydrate metabolism. Magnesium. 1984;3:315-323. PUBMED
4. Paolisso G, Sgambato S, Pizza G, Passariello N, Varricchio M, D'Onofrio F. Improved insulin in response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care. 1989;12:265-269. PUBMED
5. Rayssiguer Y. Magnesium and lipids interrelationships in the pathogenesis of vascular diseases. Magnes Bull. 1981;1a:165-177.
6. Resnick LM. Hypertension and abnormal glucose homeostasis: possible role of divalent ion metabolism. Am J Med. 1989;87(suppl_6A):17S-22S. PUBMED
7. Gemperline PJ, Miller KH, West TL, Weinstein JE, Hamilton JC, Bray JT. Principal component analysis, trace elements, and blue crab shell disease. Anal Chem. 1992;64:523A-532A. PUBMED
8. Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19:475-478.
9. Lipid Research Clinics Program. Manual of Laboratory Operation. Bethesda, Md: US Dept of Health and Human Services, National Institute of Health; 1982.
10. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparation ultracentrifuge. Clin Chem. 1972;18:499-502. FREE FULL TEXT
11. Pocock SJ. Clinical Trials: A Practical Approach. New York, NY: John Wiley & Sons Inc; 1983:114-119.
12. Senn S. Cross-over Trials in Clinical Research. Chichester, NY: John Wiley & Sons Inc; 1993:1-70.
13. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Rev ed. Orlando, Fla: Academic Press Inc; 1977:19-74.
14. Whelton PK, Klag MJ. Magnesium and blood pressure: review of the epidemiologic and clinical trial experience. Am J Cardiol. 1989;63:266-306.
15. Zemel PC, Zemel MB, Urberg M, Douglas FL, Geiser R, Sowers JR. Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension. Am J Clin Nutr. 1990;51:665-669. FREE FULL TEXT
16. Cappuccio FP, Markandu ND, Beynon GW, Shore AC, Sampson B, MacGregor GA. Lack of effect of oral magnesium on high blood pressure: a double-blind study. BMJ. 1985;291:235-238. FREE FULL TEXT
17. Lind L, Lithell H, Pollare T, Ljunghall S. Blood pressure response during longterm treatment with magnesium is dependent on magnesium status: a doubleblind, placebo-controlled study in essential hypertension and in subjects with high-normal blood pressure. Am J Hypertens. 1991;4:674-679. PUBMED
18. Dyckner T, Wester PO. Effect of magnesium on blood pressure. BMJ. 1983;286:1847-1849. FREE FULL TEXT
19. Motoyama T, Sano H, Fukuzaki H. Oral magnesium supplementation in patients with essential hypertension. Hypertension. 1989;13:227-232. FREE FULL TEXT
20. Shibutani Y, Sakamoto K, Katsuno S, Yoshimoto S, Matsuura T. Relation of serum and erythrocyte magnesium levels to blood pressure and a family history of hypertension. Acta Paediatr Scand. 1990;79:316-321. PUBMED
21. Dyckner T, Wester PO. Intracellular magnesium loss after diuretic administration. Drugs. 1984;28:161-166. PUBMED
22. Hattori K, Saito K, Sano H, Fukuzaki H. Intracellular magnesium deficiency and effect of oral magnesium on blood pressure and red cell sodium transport in diuretic-treated hypertensive patients. Jpn Circ J. 1988;52:1249-1256. PUBMED
23. Reyes AJ, Leary WP, Acosta-Barrios TN, Davis WH. Magnesium supplementation in hypertension treated with hydrochlorothiazide. Curr Ther Res. 1984;36:332-340.
24. Saito K, Hattori K, Omatsu T, Hisashi H, Sano H, Fukuzaki H. Effects of oral magnesium on blood pressure and red cell sodium transport in patients receiving long-term thiazide diuretics for hypertension. Am J Hypertens. 1988;1:71S-74S. PUBMED
25. Ferrannini E, Santoro D, Manicardi V. The association of essential hypertension and diabetes. Compr Ther. 1989;15:51-58. PUBMED
26. Fuller JH, Head J. Blood pressure, proteinuria and their relationship with circulatory mortality: the WHO multinational study of vascular disease in diabetics. Diabete Metab. 1989;15:273-277. PUBMED
27. Rasmussen HS, Aurup P, Goldstein K, et al. Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. Arch Intern Med. 1989;49:1050-1053.
28. Reaven G. Non—insulin-dependent diabetes mellitus, abnormal lipoprotein metabolism and atherosclerosis. Metabolism. 1987;36(suppl 1):1-8. PUBMED
29. Speich M, Murat A, Gelot S, Boudart D, Durlach J, Pechery C. Plasma and erythrocyte magnesium levels during diabetes mellitus: preliminary study of correlations involving eleven parameters. Magnesium. 1983;8:237-243.
30. Weidmann P, Boehlen LM, de Courten M. Is hypertension a disease? do we have to reevaluate our way of thinking? pathogenesis and treatment of hypertension associated with diabetes mellitus. Am Heart J. 1993;125(suppl 5S):1498-1513. PUBMED